USPTO grants two patents for Leto Medical's COS technology

Leto Medical, LLC, a privately held, early-stage medical device company, announced today that the United States Patent and Trademark Office has granted the company two patents (7,765,006 and 7,765,007) for its breakthrough Continent Ostomy System (COS) technology, a system of products that will restore continence control to individuals with colostomies.

“These patents are the foundation upon which Leto Medical is building its Continent Ostomy System intellectual property estate”

A colostomy is created when an individual's colon and/or rectum is partially or completely removed or bypassed and the remaining healthy portion of the intestine is brought through the abdominal wall, forming what is referred to as a stoma. Ostomy surgery leaves the individual incontinent and fully reliant on ostomy bags.

Leto's Continent Ostomy System is a family of products currently under development that will restore continence control to individuals who have been rendered incontinent as a result of colostomy surgery. The cornerstone of the System is an innovative electrical stimulation device that, when in use, will actively control the terminal segment of the individual's colon. This device, along with the System's proprietary, single-use disposables, will allow individuals with colostomies to manage their fecal output without the use of ostomy bags.

"These patents are the foundation upon which Leto Medical is building its Continent Ostomy System intellectual property estate," said Jim Schneider, President of Leto Medical. "Their issuance is an important milestone for the company. They are the first in what we believe will be a large family of patents that will protect our proprietary ostomy management technology, a technology that will improve the Quality of Life of tens of thousands of individuals with colostomies by freeing them from 24/7 dependence on ostomy bags."